Competitive Landscape and Strategic Developments in the Global Minimal Residual Disease Testing Market Market
The MRD Testing market is expected to grow from an estimated USD 1351.5 million in 2024 to USD 3901.1 million in 2033, at a CAGR of 12.50%.Flow cytometry has made significant advances since its start, but the core principles have remained mostly intact for almost 60 years, and the technology has predominantly concentrated on fluorescence-based analysis. Flow cytometry has typically relied on...
0 Commentarii 0 Distribuiri 16 Views 0 previzualizare